Lu Han

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Clinical Cancer Research · 2021 · 274 citations · Full text

Life Sciences, Immunology, Oncology +17

Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer

Lu Han, Yongbei Zhu, Zhenyu Liu et al. · European Radiology · 2019 · 195 citations

Medicine, Oncology, Radiology +16

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Cell Research · 2022 · 190 citations · Full text

Medicine, Hematology, Immunology +16

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells

Xiuman Zhou, Wanqiong Li, Yahong Wu et al. · Frontiers in Immunology · 2018 · 109 citations · Full text

Medicine, Immunology, Oncology +17

Radiomic signature as a predictive factor for lymph node metastasis in early‐stage cervical cancer

Yangyang Kan, Di Dong, Yuchen Zhang et al. · Journal of Magnetic Resonance Imaging · 2018 · 98 citations

Medicine, Oncology, Radiology +17